Increased Response of Blood Eosinophils to Various Chemotactic Agents in Quiescent Crohn Disease

References

• Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182–205.
   PubMed Web of Science ®Google Scholar
• Bischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996;28:1–13.
   PubMed Web of Science ®Google Scholar
• Dubucquoi S, Janin A, Klein O, Desreumaux P, Quandalle P, Cortot A, et al. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn’s disease. Gut 1995;37:242–6.
   PubMed Web of Science ®Google Scholar
• D’Haens G, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262–7.
   PubMed Web of Science ®Google Scholar
• D’Haens G, Colpaert S, Peeters M, Baert F, Penninckx F, Rutgeerts P, et al. The presence and severity of neural inflammation predict severe postoperative recurrence of Crohn’s disease. Gastroenterology 1998;114:G3950.
   Google Scholar
• Louis E, Louis R, Shute J, Lau L, Franchimont D, Lamproye A, et al. Bronchial eosinophilic infiltration in Crohn’s disease in the absence of pulmonary disease. Clin Exp Allergy 1999;29:660–6.
   PubMed Web of Science ®Google Scholar
• Wardlaw AJ, Walsh G, Symon A. Mechanisms of eosinophil and basophil migration. Allergy 1994;49:797–807.
   PubMedGoogle Scholar
• Kald B, Olaison G, Sjodahl R, Tagesson C. Novel aspects of Crohn’s disease: increased content of platelet activating factor in ileal and colonic mucosa. Digestion 1990;46:199–204.
   PubMed Web of Science ®Google Scholar
• Fromont Hankard G, Brousse N, Cézard JP, Emilie D, Peuchmaur M. In situ interleukin 5 gene expression in pediatric Crohn’s disease. J Pediatr Gastroenterol Nutr 1997;24: 568–72.
   Google Scholar
• Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tateishi H, Nishiyama T, et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn’s disease. Clin Exp Immunol 1994;96:432–6.
   PubMed Web of Science ®Google Scholar
• Berrebi D, Banerjee A, Paris R, Potet F, Aigrin Y, Emilie D, et al. In situ RANTES and interferon- γ gene expression in pediatric small bowel Crohn’s disease. J Pediatr Gastroenterol Nutr 1997;25:371–6.
   PubMedGoogle Scholar
• Garcia-Zepeda E, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996;2:449–56.
   PubMed Web of Science ®Google Scholar
• Best WR, Bektel JM, Singleton JW, Kern F. Development of a Crohn’s disease activity index: national cooperative Crohn’s disease study. Gastroenterology 1976;70:439–44.
   PubMed Web of Science ®Google Scholar
• Hansel TT, De Vries IJM, Iff T, Rihs S, Wanolzilak M, Betz S, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105–10.
   PubMed Web of Science ®Google Scholar
• Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med 1962;115:453–66.
   PubMed Web of Science ®Google Scholar
• Louis R, Shute J, Biagi S, Stanciu L, Marrell F, Temor H, et al. Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum. Am J Respir Crit Care Med 1997;155:466–72.
   PubMedGoogle Scholar
• Warringa RAJ, Mengelers HJJ, Kuijper PHM, Raaijmakers JAM, Bruijnzeel PLB, Koenderman L. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood 1992;79:1836–41.
   PubMedGoogle Scholar
• Lampinen M, Rak S, Venge P. The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin Exp Allergy 1999;29: 314–22.
   Google Scholar
• Schweizer RC, Welmers BAC, Raaijmakers JAM, Zanen P, Lammers J-WJ, Koenderman L. RANTES- and interleukin-8- induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood 1994;83: 3697–704.
   Google Scholar
• Petering H, Götze O, Kimmig D, Smolarski R, Kapp A, Elsner J. The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. Blood 1999;93:694–702.
   PubMed Web of Science ®Google Scholar
• Chuntharapai A, Kim J. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol 1995;155:2587–94.
   PubMed Web of Science ®Google Scholar
• Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, et al. Chemokine receptor usage by human eosinophils. J Clin Invest 1997;99:178–84.
   PubMed Web of Science ®Google Scholar
• Warringa RAJ, Koenderman L, Kok PTM, Kreukniet J, Bruijnzeel PLB. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood 1991;77: 2694–700.
   Google Scholar
• Louis E, Belaiche J, Van Kemseke C, Franchimont D, De Groote D, Geenen V, et al. A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn’s disease. Eur J Gastroenterol Hepatol 1997;9:939–44.
   PubMedGoogle Scholar
• Desreumaux P, Brandt E, Gambiez L, Emilie D, Geboes K, Klein O, et al. Distinct cytokine patterns in early and chronic ileal lesions of Crohn’s disease. Gastroenterology 1997;113:118–26.
   PubMed Web of Science ®Google Scholar
• Lorentz A, Schwengberg S, Mierke C, Manns MP, Bischoff SC. Human intestinal mast cells produce IL-5 in vitro upon IgE receptor cross-linking and in vivo in the course of intestinal inflammatory disease. Eur J Immunol 1999;29: 1496–503.
   Google Scholar
• Gelbmann CM, Mestermann S, Gross V, Kollinger M, Scholmerich J, Falk W. Strictures in Crohn’s disease are characterized by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut 1999;45:210–7.
   PubMed Web of Science ®Google Scholar
• Raithel M, Schneider HT, Hahn EG. Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease. Scand J Gastroenterol 1999;34:496–503.
   PubMed Web of Science ®Google Scholar
• Bettiol J, Radermecker M, Sele J, Henquet M, Cataldo D, Louis R. Airway mast-cell activation in asthmatics is associated with selective sputum eosinophilia. Allergy 1999;54:1188–93.
   PubMed Web of Science ®Google Scholar
• Brandt E, Muller-Alouf H, Desreumaux P, Woerly G, Colombel JF, Capron M. Circulating growth-regulator oncogene alpha contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn’s disease. Eur Cytokine Netw 1998;9:647–53.
   PubMedGoogle Scholar
• Hallgren R, Colombel JF, Dahl R, Kjell F, Kruse A, Jacobsen NO, et al. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn’s disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents. Am J Med 1989;86:56–63.
   PubMed Web of Science ®Google Scholar
• Liu H, Lazarus SC, Caughey GH, Fahy JV. Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro. Am J Physiol 1999;276(1 Pt 1):L28–34.
   Google Scholar